Mounjaro and Wegovy in pregnancy: what UK guidance actually advises

What the official advice says about conceiving on either medicine

Start with the shared ground, because it matters most. UK guidance is clear that GLP-1 medicines used for weight management, including both Mounjaro and Wegovy, are not recommended in pregnancy or while breastfeeding, and are not suitable if you're actively trying to conceive. The MHRA advises using contraception while you're on treatment and leaving a wash-out gap before you try for a baby. That advice sits behind the licensed use of both products.

The reasoning is straightforward. These medicines were studied and licensed for weight management in adults, alongside a reduced-calorie diet and more activity, not for use during pregnancy. There isn't the safety evidence to support taking them while pregnant, and animal data has raised enough concern that the sensible course is to avoid them. Weight loss itself is also not advised in pregnancy.

Practically, this means two things. If you're planning a family in the near future, treatment for weight before pregnancy is a conversation to have with a clinician about timing and a wash-out period. And if a pregnancy is unplanned while you're on either medicine, the advice is to stop and get in touch with a healthcare professional. The NHS England guidance on weight management injections covers contraception, planning and stopping in more detail, and it's a good neutral place to read the full picture rather than relying on forum advice.

The one big difference: contraception advice for Mounjaro versus Wegovy

Here is where the two medicines genuinely diverge, and it's the single most useful thing to take from this page. The advice on contraception is not identical.

For tirzepatide (Mounjaro), women using an oral contraceptive pill are advised to add a non-oral method, such as condoms, for the first four weeks of treatment and for four weeks after each dose increase. The reason is absorption: tirzepatide can reduce how well the pill is taken up by the body during those windows, which could make it less reliable. So the pill alone may not be enough at the start and after each step up.

For semaglutide (Wegovy), NHS guidance notes there is no equivalent evidence that it reduces the effectiveness of the oral contraceptive pill. Contraception is still advised while on treatment, but the specific belt-and-braces instruction about adding a barrier method around dose changes applies to tirzepatide, not to semaglutide.

That distinction is easy to miss and worth pinning down, because someone switching between the two, or comparing them, might assume the rules are the same. They aren't. If contraception reliability is a live concern for you, it's one of the practical differences our prescribers will talk through, and you can read a broader head-to-head on our the NHS overview of tirzepatide alongside our own comparison of Wegovy and Mounjaro. Never change your own contraception plan off the back of a web page; confirm it with a clinician.

How the two medicines line up on the points that matter here

A quick side-by-side helps, as long as it's read as general information rather than personal advice. Both are once-weekly injections licensed for weight management in the UK, and both carry the MHRA's Black Triangle for extra monitoring. The table below focuses on the pregnancy-relevant points.

The mechanism difference (tirzepatide acts on two gut-hormone receptors, semaglutide on one) is part of why the absorption question plays out differently, though the practical takeaway is the contraception advice, not the biology. Both slow how quickly the stomach empties and both increase fullness. If you want the numbers behind the weight results rather than the pregnancy angle, our page on how the two compare on cost and value and the broader weight-loss treatment overview go further than this page needs to.

None of this decides anything for an individual. The table shows the shape of the advice, not your answer.

Why weight-loss medicines aren't used during pregnancy at all

It can feel counterintuitive that a medicine helping with weight, and with related conditions like high blood pressure, would be paused for pregnancy. The short version: these medicines were never studied for pregnant women, and pregnancy is not the time to be aiming for weight loss.

Both Mounjaro and Wegovy are licensed specifically for weight management alongside a reduced-calorie diet and increased physical activity in adults. That licence does not extend to pregnancy or breastfeeding. Because there's a lack of human safety data in pregnancy, and because animal studies flagged potential concerns, regulators and the NHS take the cautious position of advising against use. When evidence is thin on something as important as a developing baby, the default is to avoid.

There's a second layer to it. Actively losing weight during pregnancy is generally not recommended, because a pregnancy has its own nutritional needs. The whole purpose of these medicines, reducing appetite and calorie intake to lose weight, runs against what a pregnancy requires. So even setting aside the direct safety question, the goal of the treatment doesn't fit the situation.

This is why the sequencing tends to be: address weight before conception where that's the plan, leave a wash-out gap on medical advice, then focus on a healthy pregnancy. If weight is affecting your health and you want to understand the licensed routes before any family planning, the NICE recommendation on tirzepatide (TA1026) sets out who these medicines are for. Timing around pregnancy is exactly the kind of thing worth raising early with a clinician rather than working out alone.

What to do if you conceive while taking Mounjaro or Wegovy

Unplanned pregnancies happen, and the advice here is calm and practical, not alarmist. If you become pregnant while taking either medicine, the guidance is to stop the treatment and contact a healthcare professional as soon as you can. That could be your GP, a midwife, or our clinical team if you're a nume patient.

Stopping is the right first step because neither medicine is recommended to continue in pregnancy. Getting in touch promptly means someone can review your individual situation, talk through anything you're worried about, and support you with the right care from that point. There's no benefit in panicking, and no benefit in carrying on regardless either; the sensible middle path is to pause and ask.

It's also worth knowing why the contraception advice earlier on this page exists in the first place. The whole point of advising reliable contraception, and the extra barrier method for tirzepatide around dose changes, is to reduce the chance of exactly this scenario. If you've been unsure whether your contraception was covering you fully on Mounjaro, that's a conversation to have proactively rather than after the fact.

If side effects have been part of your experience and you want to report anything, the MHRA's Yellow Card scheme lets patients report suspected side effects directly. For anything urgent or health-related in pregnancy, though, speaking to a professional comes first. Our prescribers review every case individually, and you can reach the team through our contact page if you need to raise something quickly.

Ozempic, Rybelsus and the products that aren't for weight loss

People comparing pregnancy advice sometimes lump several medicine names together, so it's worth being precise about what is and isn't a weight-loss treatment. This clears up a common source of confusion.

Ozempic is semaglutide, the same active ingredient as Wegovy, but it is licensed in the UK for type 2 diabetes, not for weight loss. Rybelsus is oral semaglutide, again licensed for type 2 diabetes rather than weight management. Neither should be treated as an interchangeable weight-loss option, and neither changes the core pregnancy message: GLP-1 medicines are not recommended in pregnancy, and contraception is advised on treatment. The general caution around conceiving applies across this class of medicine.

The reason this matters for a pregnancy-focused page is that advice you read about "Ozempic and pregnancy" is really advice about the same molecule as Wegovy, but the licensed purpose is different. If your interest is weight management, the two products a UK online pharmacy like ours dispenses are Mounjaro and Wegovy, both prescription-only and both requiring a full clinical assessment first.

nume is a clinician-led service with its own GPhC-registered pharmacy, and you can verify our registration (number 9012878) on the GPhC register. That check is worth doing for any online pharmacy. You can read more about who we are on our about page and meet the clinical lead behind our prescribing on our clinical team profile.

How nume approaches this before and around treatment

If you're weighing up treatment and pregnancy is anywhere on your horizon, the honest answer is that it's a clinical conversation, not a box to tick. Our consultation exists precisely to catch questions like this one.

Every consultation with nume is read by a GPhC-registered Independent Prescriber the same day, not sorted by software. A real clinician looks at your answers, including anything about contraception, family planning, or trying to conceive, and they factor that into whether treatment is suitable and, if so, how to approach contraception advice safely. Pregnancy, breastfeeding and actively trying for a baby all fall outside what these medicines are for, so this is squarely within what the assessment is designed to consider.

Assuming treatment is clinically appropriate, the practical side is straightforward. Order by 12pm on a weekday and, once approved, your treatment is dispatched the same day for free next-working-day DPD delivery. It arrives in a plain, unbranded box you can track on your phone, with the pen inside kept properly cold. Everything sits under one transparent price, with no subscription and a fresh clinical review before every repeat.

We're deliberately not the cheapest option, and for a prescription medicine that's not the measure that keeps you safe anyway. If you'd like to see whether treatment fits your situation, the best next step is to start the free assessment and let a prescriber weigh it up with you. You can also browse the full range on our weight-loss treatments hub or read the general FAQs first.

Related questions we've answered

• How Wegovy and Mounjaro compare overall
• Tirzepatide versus semaglutide on cost
• The treatments nume dispenses
• The clinician behind our prescribing